Table of Contents Table of Contents
Diabetes Research and Clinical Practice - Volume 120 - Supplement 1 - October 2016 Next Page
Information
Show Menu
Diabetes Research and Clinical Practice - Volume 120 - Supplement 1 - October 2016 Next Page

 


Aims and Scope and Editorial Board 		3
Congress Information 		6
Abstracts of the 11th IDF-WPR Congress 2016 & 8th AASD Scientific Meeting 27th-30th October, 2016, Taipei, Taiwan 		6
About 		7
Program at a glance of the 11th IDF-WPR Congress 2016 & 8th AASD Scientific Meeting 		8-9
Contents 		16
Speech Abstracts 		19
Keynote Lecture 		19
KN-01 Adiponectin and its receptors: A major role in type 2 diabetes and obesity-linked diseases 		19
Plenary Lecture 		19
PL-01 Diabetes: Is this the greatest epidemic in the history of mankind 		19
PL-02 From p-values to proteins: Using genetic and genomic data to deliver biological insights and clinical opportunities for type 2 diabetes 		19
PL-03 Precision medicine 2016: Opportunities & challenges 		20
Presidential Lecture 		20
PR-01 The unrelenting challenge of diabetes in our world: Small step and big changes 		20
PR-02 Biological role of ALDH2 in metabolic diseases – Asian perspectives 		20
Current Diabetes Burden and Performance in WPR 		20
S01-1 DiabCare Malaysia: Journey to improving diabetes care in Malaysia 		20
S01-2 Diabetes care in Australia 		21
S01-4 Meeting the needs of diabetes care in old people 		21
S01-5 Current diabetes care status in Korea 		21
S05-1 Social-economic impact of diabetes in New Zealand 		22
S05-2 Socio-economic impact and initiatives of diabetes in Indonesia 		22
S05-3 Landscape of diabetes in the Philippines 		23
Who Does What in the Health Care for Diabetes in Taiwan 		23
S12-3 Health governance and strategy and the challenge of noncommunicable diseases: Viewpoints from lifestyle intervention in diabetes prevention 		23
Update of Bariatric/Metabolic Surgery 		24
S02-1 Current status of bariatric/metabolic surgery: ADSS data 		24
S02-4 Management of residual diabetes and micronutrient deficiencies after bariatric surgery 		24
Screening of Diabetes: How and Why? 		25
S03-1 Screening and diagnosis of diabetes mellitus in Taiwan 		25
S03-3 National survey on diabetes in China 		25
Childhood Obesity and Diabetes: Environmental Risk Factors, Screening, and Intervention 		25
S06-1 Environmental factors associated with obesity and diabetes in Taiwanese children 		25
S06-2 Screening of childhood type 2 diabetes in Japan 		26
S06-3 The optimal exercise modality for childhood obesity prevention and treatment 		26
Genetic Architecture of T2DM 		26
S04-1 Genetic and genomic approaches to dissecting the pathogenesis of diabetes 		26
S04-2 Recent progress in genetic research on type 2 diabetes and obesity in East Asian populations 		26
Mitochondria in Diabetes 		27
S07-1 ERK-c-Myc pathway as a novel pathway linking mitochondrial dysfunction and skeletal muscle insulin resistance 		27
S07-2 Mitochondrial dysfunction and dysregulation of Ca2+ homeostasis in insulin insensitivity and diabetes 		27
S07-3 Study of insulin resistance and chronic inflammation in cybrid cells harboring diabetes-susceptible mitochondrial haplogroups 		27
S07-4 Metabolism-secretion coupling in diabetic islets 		28
The Role of Epigenetics in Diabetes and its Complications 		28
S10-3 Co-localization of NFIA and PPARγ controls the brown fat gene program 		28
Environmental Pollutants and Diabetes 		28
S17-1 Obesity and diabetes: roles of circulating environmental pollutants and its mitochondria inhibiting activity in pathogenesis 		28
S17-2 Environmental pollutants and cardiovascular diseases 		29
S17-3 Are persistent organic pollutants a common soil of type 2 diabetes and type 3 diabetes (dementia)? 		29
S17-4 Endocrine disrupting chemicals and risk of type 2 diabetes and cardiovascular disease: Focused on phthalates and perfluorinated chemicals 		29
Cardiovascular Disease and Diabetes— Clinical and Translational 		29
S08-1 Basic science of diabetic cardiomyopathy– a mechanism and role of mitochondria dysfunction 		29
S08-2 Inspiration from the historical evolution of large-scale clinical studies in diabetes–the cardiovascular safety of hypoglycemic therapy 		30
DM Nephropathy: Risk, Mechanism, Management and Outcome 		30
S15-2 Individualized blood pressure targets in Asian diabetic patients with or without nephropathy 		30
S15-3 Choice of antidiabetic agents and glycemic goals in patients with diabetic kidney disease 		30
Diabetic Neuropathy: Clinical Update 		31
S21-1 How to approach the patient with diabetic neuropathy– Screening and diagnosis 		31
S21-2 Current and future strategies for treatment of diabetic neuropathy 		31
S21-3 Recent management of diabetic distal symmetric polyneuropathy 		32
Diabetic Eye Disease: Early Detection, and Treatment 		32
S25-1 Epidemiology of diabetic retinopathy, diabetic macular edema and vision loss due to diabetes 		32
S25-2 The pathogenesis and risk factors of diabetic retinopathy and macular edema 		32
S25-3 Diabetic eye diseases 		32
Diabetes Foot: Learning from Diabetes Foot Care Program 		32
S31-1 Diabetic foot problems and education programme on the diabetic foot in Western Pacific Region 		32
S31-2 Foot care in diabetes in Australia 		33
S31-3 From multidisciplinary care for limb-threatening diabetic foot ulcers in a university hospital to the ongoing diabetic foot working group in Taiwan 		33
Pancreas Transplantation 		33
S09-1 Pancreas transplantation in Korea 		33
S09-3 Pancreas transplant – Taipei Veterans General Hospital experience 		34
Islet Transplantation 		34
S16-1 Current status of clinical islet transplantation 		34
S16-2 Clinical islet transplantation from allogeneic toward xenogeneic 		34
S16-3 Clinical islet autotransplantation: Beyond simple replacement of islet cell mass 		35
Stem Cell Therapy 		35
S22-1 Expandable human pancreatic progenitor cells – a novel inroad toward the production of β cells 		35
S22-2 Generation of insulin-producingβ-like cells from human iPS cells 		35
S22-3 Autologous hematopoietic stem cell transplantation in type 1 diabetes 		35
S22-4 Amelioration of type 1 diabetes using direct hepatocyte reprogramming approaches 		36
Islet Imaging 		36
S26-1 Non-invasive pancreatic beta-cell imaging using radiolabeled exendin probe 		36
S26-2 Magnetic resonance imaging of islet grafts 		36
Orally Administered Antidiabetic Agents 		37
S11-3 Multifunctional nanoparticles for oral protein drug delivery 		37
Injectable Antidiabetic Agents (I): GLP-1 Receptor Agonists 		37
S18-1 Pleiotropic actions of GLP-1 RA 		37
S18-2 Incretin-based therapy on diabetic nephropathy 		37
S18-4 GLP-1 receptor agonists and cardiovascular safety 		38
Injectable Antidiabetic Agents (II): Insulin 		38
S28-2 New developments in basal insulin therapies 		38
S28-3 New era in insulin therapy: the ultra-fast acting insulins 		38
S28-4 Development of glucose-responsive “smart” insulin 		38
Closed-Loop System and CGM 		39
S33-1 The use of closed loop in outpatient/home studies 		39
S33-2 Redefining diabetes management by technology in children with diabetes: from insulin pumps and continuous glucose monitors to the artificial pancreas system 		39
Obesity and Diabetes 		39
S13-1 Roles for adipose ceramides in metabolic homeostasis 		39
S13-2 Roles of G6PD in ROS and inflammatory responses of obese adipose tissue 		39
S13-3 Obesity, inflammation and diabetic kidney disease 		40
S13-4 The relationship between obesity and insulin resistance in Asian patients 		40
S13-5 17β-hydroxysteroid dehydrogenase-13 is a lipogenic lipid droplet-associated protein and is regulated by an LXRαSREBP1c axis in the liver 		40
Adipocyte Biology and Insulin Resistance 		40
S20-1 Lipid dynamics in brown fat-mediated thermogenesis and energy metabolism 		40
S20-2 HOXC10 suppresses browning of white adipose tissues 		41
S20-3 Inactivation of the E-Prostanoid 3 receptor gene causes adiposity and insulin resistance via altering white adipose tissue metabolism 		41
S20-4 Regulation of hepatosteatosis and obesity by sphingolipids 		41
S20-5 Targeting fat metabolismand energy expenditure inmetabolic disease 		41
Hot Topics in Diabetes and Obesity (I) 		41
S24-1 Molecular mapping of insulin action and insulin resistance 		41
S24-2 The metabolic consequences of fecal microbiota transplantation (FMT) in mice 		42
S24-3 Chronic exercise alleviates obesity-related metabolic dysfunction by enhancing FGF21 sensitivity in adipose tissues 		42
S24-4 Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of type 2 diabetes: 12month results of a double-blind, randomised trial 		42
Incretin/Islet Biology and Insulin Secretion 		43
S30-1 β-cell glutamate signaling in insulin secretion: the physiological and pathophysiological roles 		43
S30-2 Intracellular membrane trafficking and insulin secretion 		43
S30-3 Sorcs1: From diabetes quantitative trait locus to cellular function 		43
S30-4 New insights into mechanisms regulating insulin secretion 		43
S30-5 Role of Activin B/FSTL3 axis in the control of glucose homeostasis 		43
Hot Topics in Diabetes and Obesity (II) 		44
S35-1 Role of CRTC2 in the control of glucose metabolism 		44
S35-3 Significance of adiponectin accumulation in vasculature 		44
S35-4 Hypothalamic inflammation in high fat diet-induced obesity 		44
Hot Topics in Diabetes and Obesity (III) 		44
S38-1 Feeding-induced activation of beta-catenin/TCF signal transduction in hypothalamic neurons 		44
S38-4 Role of mitochondrial quality control in hyperglycemic neuroprotection 		45
Nutrition and Exercise in Diabetes 		45
S19-2 Alternative health eating index and the Dietary Guidelines from American Diabetes Association both may reduce the risk of cardiovascular disease in type 2 diabetes patients 		45
Diabetes Education: Patient Centered Approach 		46
S29-1 Personalised diabetes care: What is it, and does it ‘work’? 		46
S29-2 Going even further, from counselling to motivating: a universal patient-centered approach to provoke behaviour modifications in your patients 		46
Peer Leaders in Diabetes Management 		46
S34-2 Effectiveness of peer leaders in diabetes self-management support 		46
S34-3 Experiences of peer support for diabetes in China: from urban to rural 		47
Using Health Information Technology for Diabetes Care 		47
S37-2 The use of internet health education for prevention of diabetes in the workplace: From the perspectives of human beings and living processes 		47
S37-3 The evaluation of patients’ use of tele-health program 		47
Associations of Life Events/Life Stress with Diabetes Control 		48
S27-1 Diabetes control in the life context: Support for reconciling self-management and lifestyle 		48
Association of Daily Problem Solving/ Coping/Social Supports with Diabetes Control 		48
S32-1 Impact of the peer counseling for dissolving a negative cognition toward diabetes 		48
S32-3 The relationship between coping strategies of DMand diabetes control 		49
Association of Psychosocial Factors with Diabetes Control 		49
S36-1 Mental states of individuals with type 2 diabetes by psychological assessment 		49
Taiwanese Diabetes Care 3.0–Improving Efficiency through Automation 		50
SP02-2 Improving self-management and diabetes education programs through analytics and automation 		50
SP02-3 Assessment of the cost-effectiveness and clinical outcomes of a fourth generation synchronous telehealth program for the management of chronic cardiovascular disease: A longitudinal study 		50
Using Big Data for Research and Care in Diabetes 		51
SP03-1 Big data from bench to bedside to population in diabetes care 		51
WPR Disaster Program 		51
SP04-1 IDF WPR natural disaster program: What next? 		51
SP04-3 Disasters and patients with diabetes – an endocrinologist’s experience in missions in Africa and the Philippines 		52
Integration of Diabetes Management in Taiwan 		52
S39-1 Overcoming difficulties and pursuing excellence 		52
S39-2 Diabetes case management: Improvement measures at Changhua Christian Hospital 		52
S39-3 Experience of diabetes management in an integrated polyclinic of Taiwan 		52
Self-Management of Diabetes Education 		53
S40-1 The role of shared decision making in diabetes education 		53
Lunch Seminar – LG Life Science 		53
LN02-1 Optimizing glucose control with gemigliptin in type 2 diabetes 		53
Lunch Seminar – Servier 		54
LN04-1 Update on existing therapy– with a focus on SUs 		54
Lunch Seminar – Boehringer-Ingelheim 		54
LN09-1 New horizons for managing type 2 diabetes 		54
LN09-2 EMPA-REG OUTCOME®: Macrovascular and microvascular outcomes 		55
Lunch Seminar – Takeda 		55
LN10-1 Collaborations & combinations: Spotlight on high CV risk and T2D patients in Asia 		55
Lunch Seminar – Ascensia 		55
LN11-1 Accuracy and user performance evaluation as key factors in self-monitoring in diabetes patients 		55
Lunch Seminar – AstraZeneca 		55
LN14-1 Is there a unifying hypothesis to explain the cardio-renal benefit of SGLT2 inhibitors? – Spotlight on the role of ketone bodies 		55
Lunch Seminar – Zespri 		56
LN15-1 Kiwifruit – A double agent for glycaemic control and nutrient enhancement 		56
Lunch Seminar – Boehringer-Ingelheim 		56
LN17-1 Translation into clinical practice: New findings in linagliptin 		56
LN17-2 Reality of insulin initiation in Type 2 Diabetes Mellitus 		57
Oral Presentations 		58
Epidemiology and Prevention of Diabetes 		58
OL01-2 Characteristics of abnormal oral glucose tolerance test in GDM diagnosis 		58
OL01-3 Increased risk for diabetes development in subjects with large variation in total cholesterol levels in Koreans 		58
OL01-4 Central blood pressure and insulin sensitivity after an oral glucose loading 		58
OL01-5 High diagnosis lag in diagnosis of type 2 diabetes mellitus: Need of the hour 		59
OL01-7 The influence of oral contraceptives on the prevalence of diabetes in postmenopausal women: 2007–2012 KNHANES 		59
Pathogenesis of Obesity, Diabetes, and Diabetic Complications 		59
OL02-1 Possible role of hepassocin in chronic social defeat-induced metabolic disturbance 		59
OL02-2 The role of casein kinase 2 in ER stress associated pancreaticβ cell failure 		60
OL02-3 A surge of appetite regulating hormone, ghrelin, and its relevance to motivation for the initiation of voluntary exercise in mice 		60
OL02-4 Attenuation of high fatty acid-induced hepatic lipotoxicity and insulin resistance by induction of miR-302 		61
OL02-5 One-year post-transplant hyperglycemia aggravated kidney function in diabetic patients 		61
OL02-6 Abrogation of Toll-like receptor 4 (TLR4) mitigates obesityinduced insulin resistance and glucose intolerance through reducing mitochondrial ROS in visceral fat 		61
OL02-7 Interaction of TET-1 and OGT enzymes regulates epigenome modification and high-glucose induced renal proximal tubular cell injury 		62
OL02-8 Astaxanthin prevents and reverses insulin resistance and steatohepatitis: A comparison with vitamin E 		62
Diabetes Complications: Epidemiology and Biomarkers 		63
OL03-1 Examination of sleep disorders of 1023 type2 diabetic outpatients 		63
OL03-2 Global and Chinese prevalence of diabetic foot 		63
OL03-3 Bilateral atrophy of extensor digitorum brevis muscle may be useful for diagnosis of diabetic polyneuropathy in Japanese diabetic men 		63
OL03-4 Risks of progression to end-stage renal disease among type 2 diabetic patients with albuminuric and non-albuminuric chronic kidney disease 		64
OL03-5 High prevalence of cardio-renal complications among Chinese subjects with Type 2 diabetes – The Hong Kong Diabetes Biobank 		64
OL03-6 The relation between urinary albumin excretion rate (AER) and peripheral artery disease in Taiwanese diabetic patients 		65
OL03-7 Characteristics of Korean T2DM patients with diabetic retinopathy and macular edema: A Study based on a standardized clinical data 		65
OL03-8 A novel scoring system for detecting diabetic kidney disease predicts renal function decline in patients with type 2 diabetes 		65
Genetics and Epidemiology 		66
OL04-3 The association of GIPR variants with fat accumulation in Chinese Han populations 		66
OL04-4 Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk 		66
OL04-5 Computational analysis of type 2 diabetes associated SNPs and genes identified by GWASs 		66
OL04-6 Association between GWAS-identified variants with CKD in Chinese with Type 2 Diabetes: The Hong Kong Diabetes Registry 		67
OL04-7 Genome-wide association study in Chinese identifies new susceptibility loci associated with chronic kidney disease in type 2 diabetes 		67
OL04-8 Identification of a mutation associated with early-onset diabetes in the intron of INS gene with whole-exome sequencing 		68
Treatment of Diabetes 		68
OL05-1 Medicine-related factors that could impact on the safety and outcomes of glucose lowering medicines (GLM) in aged care home 		68
OL05-2 Changes in body composition during SGLT2 inhibitor treatment and their relevance to the improvement of insulin sensitivity 		68
OL05-3 Efficacy and safety of once-weekly semaglutide vs exenatide ER after 56Weeks in subjects with type 2 diabetes (SUSTAIN 3) 		69
OL05-4 Efficacy and safety of once-weekly semaglutide versus oncedaily insulin glargine in insulin-naïve subjects with type 2 diabetes (SUSTAIN 4) 		69
OL05-5 Effects of SGLT2 inhibitor luseogliflozin under different dietary formula in type 2 diabetes: A randomized, controlled exploratory trial 		70
OL05-6 Use of the Japanese health insurance claims database to assess safety of SGLT2 inhibitors in the management of diabetes 		70
The Pancreatic Islet and Bariatric Surgery 		70
OL06-1 Clock gene dysregulation induced by chronic endoplasmic reticulum stress disrupts β-cell function 		70
OL06-2 Effect of heparan sulfate proteoglycan Syndecan-4 on the insulin secretory response 		71
OL06-3 Elucidation of mechanism of human pancreatic beta-cell maturation with hiPSC reporter line 		71
OL06-4 The effect of caveolin-1 on the process of proliferation and apoptosis and function regulation in beta cell 		71
OL06-5 Disruption of peripheral clock gene Nocturnin leads to defective islet beta cell function and glucose intolerance 		72
OL06-6 Durability of diabetes remission after bariatric surgery: A 5year prospective follow-up in a multi-ethnic Asian population 		72
OL06-7 Metabolic surgery for Type 2 Diabetes Mellitus in young-onset patients 		72
OL06-8 Metabolic surgery for diabetes treatment: A comparative study of sleeve gastrectomy and gastric bypass 		73
Laboratory Medicine for Diabetes 		73
OL07-1 Time-dependent sensor performance is sustained during 4 years: Accuracy measurement with mean absolute difference (MAD) in continuous glucose monitoring (CGM) 		73
OL07-3 Validation of a new formula (SMART2D) for estimation of LDL cholesterol in patients with and without diabetes 		73
OL07-5 Elevated hemoglobin A1c levels are associated with increased arterial stiffness in a Taiwanese population 		74
OL07-6 Urine albumin/creatinine ratio is a significant predictor for incident diabetic peripheral neuropathy in patients with Type 2 Diabetes: 3-year prospective study 		74
OL07-7 Relationship between blood neutrophil–lymphocyte ratio and chronic kidney disease in overweight and obese adult population 		75
OL07-8 The risk factors for asymptomatic pyuria among the patients with type 2 diabetes 		75
Nutrition, Diabetes Education and Management Systems 		75
OL08-1 Whole grain intakes are associated with better ABC control in patients with type 2 diabetes in Taiwan 		75
OL08-2 Chinese physician–patient communication at T2D diagnosis and links between patient-perceived communication quality and patient outcomes: Insights from the IntroDia™study 		76
OL08-3 Multidimensional effects of a diabetes management program in a Taipei community hospital – a 7-year prospective followup study 		76
OL08-5 Intervention outcomes from a randomised controlled trial of diabetes prevention: Mothers after Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) 		77
OL08-6 Program engagement in a randomised controlled trial for diabetes prevention: Mothers after Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) 		77
OL08-7 Clinical application of a self-reported diabetic-behavior assessment computerized program in management of patients with type 2 diabetes mellitus 		78
OL08-8 Fidelity: The missing dimension in structured diabetes education around the globe 		78
Novel Treatment for Diabetes and Diabetic Complications 		78
OL09-2 GLP-1 action attenuates breast cancer growth and progression 		78
OL09-3 Activation of heat shock response improves glucose metabolism and inflammation in obese subjects with type 2 diabetes 		79
OL09-7 Dipeptidyl peptidase-4 inhibitor prevents diabetic nephropathy through STRA6 signaling 		79
OL09-8 Trans-S-1-propenyl-l-cysteine sulfoxide fromAllium cepa (onions) has appreciable antidiabetic potential in streptozotocin-induced diabetic mice 		79
Novel Biomarkers for Diabetes 		80
OL10-2 Pre-beta HDL in type 2 diabetes mellitus 		80
OL10-3 The association among cardiotrophin-1, insulin resistance and nonalcoholic fatty liver disease 		80
OL10-5 The role of irisin in components of metabolic syndrome, insulin secretion and resistance in schoolchildren 		81
OL10-6 Association between 1,5-anhydroglucitol and early-phase insulin secretion in Chinese patients with newly diagnosed type 2 diabetes mellitus 		81
OL10-7 Increases in urinary N-acetyl-β-D-glucosaminidase excretion are associated with increased arterial thickness and presence of carotid plaques in type 2 diabetes 		81
OL10-8 Validation of a novel biomarker panel, DNlite, for management of renal complication in type 1 diabetes 		82
Poster Presentations 		83
Early Screening and Intervention of Prediabetes and Diabetes 		83
PA-01 The impact of age on fasting plasma glucose-based screening algorithms for gestational diabetes mellitus 		83
PA-02 Improvement on risk factors of metabolic syndrome by community activities in small to medium hospital-study from local hospital in Kaohsiung 		83
PA-03 Effects of exercise program on normal responsiveness of serum GDF15 in middle-aged women 		83
PA-04 Association between serum white blood cell counts and hemoglobin A1c in a Korean adult population 		84
PA-05 Incidental risk for diabetes according to the change level of body mass index in Korean men 		84
PA-06 Elevated circulating plasma miRNA27b-3p in type 2 diabetes and reduced miRNA3195 in diabetic nephropathy 		84
PA-07 The presence and the extent of gastric atrophy are inversely associated with incident diabetes 		85
PA-08 Changes in lifestyle habits and subsequent risk of type 2 diabetes in males and females 		85
PA-09 Gender differences in plasma growth arrest-specific protein 6 levels in adult subjects 		86
PA-10 Glucose-dependent insulinotropic peptide level is associated with the development of type 2 diabetes mellitus 		86
PA-11 The relationship between body composition, glycemic index, and glycemic response of foods in healthy Indonesian adults 		86
PA-12 Chronic kidney disease and peripheral artery disease in type 2 diabetes 		86
PA-13 The relationship between hyperglycemic clamp and low dose graded glucose infusion in quantifying second phase insulin secretion 		87
PA-14 Clinical pictures associated with borderline heteroplasmy rate of 3243 mitochondrial tRNA Leu (UUR) mutation in type 2 diabetes 		87
PA-15 The correlation between lifestyle factors and subclinical neuropathy in patients with type 2 diabetes 		87
PA-16 Insulin significantly changes the expression of T1DM mice’s circulating microRNA 		88
PA-17 The differences of metabolic syndrome in elderly subgroups: A special focus on young-old, old-old and oldest old 		88
PA-18 Diabetes nurse case management: Improving the health of diabetes high-risk groups 		88
PA-19 Association of uric acid concentrations and metabolic syndrome in Taiwan elderly population 		88
PA-20 The correlation between carbohydrate food intake and nutritional knowledge, attitude, behavior and self-efficacy among community people 		89
PA-21 Comparison of diabetes conversion rates among Chinese prediabetic population using different diagnosis criteria 		89
PA-22 Improvement of hemoglobin A1c by a diet adherence monitoring for diabetic inpatients ordering diabetes meals 		89
PA-23 Relationship of neck circumference to metabolic syndrome and central obesity in regional hospital employees 		90
PA-24 The role of medical nutrition therapy on components of metabolic syndrome in community-based population 		90
PA-25 Low lung function associated with type 2 diabetes risk in Chinese older people: Data from the Qingdao Aging Study 		90
PA-26 Risk for cardiovascular diseases based on relationship between post-load and fasting plasma glucose levels in the normal range 		90
PA-27 The correlation of diabetic status, ischemic and atrophic burdens and cognitive decline in diabetic patients with cognitive impairment 		91
PA-28 Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter study 		91
PA-29 Optimization of diabetes screening and diabetes risk assessment in Australian community pharmacy settings: Current evidence and future directions 		92
PA-30 Partnering with general practitioners to improve access of diabetes education for patients and caregivers 		92
PA-31 Serum vascular adhesion protein-1 is associated with obesity and predicts incident diabetes 		92
PA-32 Vegetarian diet lowers the incidence of diabetes in a Taiwanese Buddhist population 		93
PA-33 The effect of Medical Nutrition Therapy on metabolic risks patients 		93
PA-35 Matsuda index and clinical indicators of insulin resistance in obese children and adolescents. Is there a correlation? 		93
PA-36 Reduced complexity of glucose dynamics is associated with poor control patients among patients with type 2 diabetes 		94
PA-37 The effect of medical nutrition therapy in diabetic patients with early chronic kidney disease 		94
Diabetes Management: Gene and Environment 		94
PB-01 Two-year efficacy and safety of moderately-low-carbohydrate diet 		94
PB-02 Comparison of epidemiological, clinical, laboratory and radiological features of diabetic and non-diabetic patients with pulmonary tuberculosis at Calmette Hospital, Cambodia 		94
PB-03 Metabolic endotoxemia and an alterlation in the gut microbiota composition are present in Japanese type 2 diabetes 		95
PB-06 High glucose induces human endothelial dysfunction through an Axl-dependent mechanism 		95
PB-07 Mitochondrial diabetes associated with tRNA Leu (UUR) mutation at position 3271 and two times of GAD antibody negative conversion 		95
PB-08 Evaluation of the web-based nutritional management program for pregnant women with diabetes mellitus 		96
PB-09 Study of frailty prevalence and status of elder diabetic patients in a primary care clinic 		96
PB-10 Association study of WFS1 rs10010131 and type 2 diabetes microvascular complication in a Chinese population 		96
PB-11 In type 2 diabetes, smoking cessation is associated with deterioration in glycemic control and this is unrelated to weight gain 		97
PB-12 New findings of genetic determinants of sulfonylurea efficacy from next-generation sequencing in sulfonylurea sensitive patients 		97
PB-14 Impact of diabetes and Intercellular adhesion molecule-1 genetic polymorphism on coronary artery disease susceptibility in Taiwan 		97
PB-15 Gain of muscle strength inmitochondrial diabetes treatedwith SGLT2 inhibitors 		98
PB-16 Mitochondrial diabetes and subjective hypoglycemia unawareness 		98
PB-17 A case of diabetes with severe peripheral neuropathy who had negligible level of mitochondrial tRNA Leu (UUR) mutation at position 3243 		99
PB-18 A case of mitochondrial diabetes associated with 3243 bp tRNA Leu (UUR) mutation, who suffered from the rapid appearance of “mitochondriopathies” 		99
PB-19 Two times elevation of CA19-9 in mitochondrial diabetes associated with tRNA (Leu) at position 3271 		100
PB-20 Potential non-laboratory predictors of fitness and status of insulin resistance among young adult Futsal players 		100
PB-21 Presentation of type 2 diabetes in children and adolescents–A single centre experience 		100
PB-22 Association of glucokinase regulator genetic variant and metabolic syndrome in Taiwanese adolescents 		101
PB-23 Potent anti-obesity effect of acetate; acetate may alter the expression of genes involved in beige adipogenesis in obese KK-Ay mice 		101
PB-24 Low skeletal muscle mass is associated with increased mortality in postmenopausal women with type 2 diabetes mellitus 		101
PB-25 The influence of diabetes on eradication rate of Helicobacter pylori 		102
PB-26 The glycemic control of adult population in Nauru 		102
PB-27 Association between CAG repeat length polymorphism of androgen receptor gene, cardio-metabolic risk factors and clinical outcomes in Chinese men 		102
PB-28 An investigation on the factors of diabetic patients’ cognition of diabetic control indicators 		103
PB-31 Green tea but not coffee consumption is inversely associated withmetabolic syndrome; An epidemiological study in Korean adults 		103
PB-32 Anti-tissue transglutaminase autoantibodies and DQB1 genotypes in patients with type 1 diabetes 		103
PB-33 The association of YKL-40 genetic polymorphisms with coronary artery disease in Taiwan population and diabetes subgroup 		104
PB-34 Facial flushing and blood pressure among Cambodians with T2D 		104
Diabetes Performance Measures: An Update and Future Directions 		104
PC-01 Demographic and clinical features of diabetes mellitus in Tuvalu patients 		104
PC-02 Targeted Active Recruitment for Intervention (TARIN) for patients with type 2 diabetes (T2DM) in general medical specialist outpatient clinics 		105
PC-03 Results of the comprehensive care model for the care of children with new-onset Type I diabetes 		105
PC-04 Dietary intake in elderly type 2 diabetes subjects in Taiwan 		106
PC-05 Utilizing diet behavior and knowledge for improving the nutritional care of type II diabetes patients 		106
PC-06 Metabolic outcome for pay for performance for diabetes care– An example from a regional teaching hospital in Taiwan 		106
PC-07 The correlation with continuity of care and diabetic foot in Taiwan 		106
PC-08 A patient centred care service model for enhancing Diabetes Mellitus management in primary care 		107
PC-09 Effects of resistance exercise in the deteriorations of cardiac contractility and mitochondrial uncoupling in cardiac muscle of diabetic animal model 		107
PC-11 The relationships between fasting plasma glucose and insulin resistance, first-, second-phase insulin secretion and glucose effectiveness in adolescents 		107
PC-12 Regulation of vascular BK channels in diabetes by Nrf2 signaling 		108
PC-13 Essential oil from sudachi peal improves glucose and lipid metabolism# 		108
PC-15 Construct an IDNT-NCP computer program for clinical management of patients with Diabetes Mellitus 		108
PC-16 Ratio of insulin cessation in patients with new onset insulin usage 		109
PC-17 The impact of seasonal lifestyle changes on glycemic control in T2DM– Based on Diabetes Case Management Program 2001, Taiwan 		109
PC-18 Geographic difference of barriers to insulin initiation in primary care physicians in Taiwan 		109
Optimizing Diabetes Therapy 		109
PD-01 The association of glycated albumin and hemoglobin A1c with glycemic excursions in Chinese type 2 diabetic patients 		109
PD-02 Effectiveness of diabetes quality improvement program in Chia-yi region of Taiwan 		110
PD-03 Diabetic medications seldom deintensified in oldest old diabetic patients – Lessons from Thailand 		110
PD-04 Better improvements of indicators of β-cell function and insulin resistance with liraglutide compared to sitagliptin in Chinese T2DM patients 		110
PD-05 Association between serum somatostatin levels and glucoselipid metabolism in the Jino ethnic minority and Han Chinese population 		111
PD-06 Efficacy and safety of SGLT2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes 		111
PD-07 Self-perceived low-carbohydrate dieters in diabetes clinic in Japan and their actual behavior 		112
PD-08 Effect of the therapy of weekly-GLP1 analog given monthly to eldery type 2 diabetes patients 		112
PD-09 Insulin intensification with basal plus mealtime insulin or mid-mixture premixed insulin in type 2 diabetes in real-world clinical practice 		112
PD-10 Kidney function assessment based on eGFR may broaden metformin eligibility rather than serum creatinine 		113
PD-11 Improving postprandial blood glucose of type 2 diabetes patients 		113
PD-12 The effectiveness of diabetes care by using multiple interventions 		113
PD-13 Metformin suppresses gastric cancer cell growth through inducing cell cycle arrest at G2/M phases 		113
PD-16 Clinical effectiveness study of dapagliflozin as add-on for 33 inadequate glycemic control patients using liraglutide and OADs 		114
PD-17 Clinical effectiveness of liraglutide as add-on therapy after OADs failure for two years in 77 type 2 diabetes cases 		114
PD-18 An observational study of diabetes outpatients switching from glargine or detemir to degludec 		115
PD-19 Different effect of testosterone and estrogen on urinary excretion of metformin via regulating OCTs and MATEs expression in the kidney 		115
PD-20 Comparison of acarbose versus voglibose monotherapy on GLP-1 secretion and postprandial dyslipidemia in patients with type 2 diabetes 		115
PD-21 Influence on urination of SGLT2 inhibitor in type 2 diabetes 		116
PD-22 Assess the efficacy differences of using long-acting insulin and oral hypoglycemic agents in type 2 diabetes patients 		116
PD-23 The use and the appropriateness of antidiabetic agents in primary referral hospital 		116
PD-24 Characteristics of the nutritional status of the Korean diabetic patients by the nutritional care process model 		117
PD-25 Empagliflozin, a sodium-glucose cotransporter 2 inhibitor, suppresses the progression of atherosclerosis in diabetic apoEdeficient mice 		117
PD-26 Increased grip strengthwith SGLT2 inhibitors: Sub-analysis by BMI, a new insight to EMPA-REG OUTCOME Study 		117
PD-27 Blood glucose self-monitoring and control for diabetes patients before and after receiving basic insulin therapies 		118
PD-28 Comparing the effects between atorvastatin 40 mg and vytorin 10/20 mg on lipoprotein parameters and inflammatory markers among dyslipidemic T2DM 		118
PD-29 The results of utilizing twice daily premixed insulin and lifestyle therapy for treating Type II diabetes 		118
PD-30 Combination of liraglutide and sitagliptin therapy improves glycemic control in Japanese patients with type 2 diabetes mellitus 		119
PD-31 Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance 		119
PD-32 Assessment of Romanian Type 2 Diabetes patients treated with insulin glargine after failure of non-insulin therapy in daily clinical practice 		119
PD-33 Ipragliflozin, a novel SGLT2 inhibitor, improves blood glucose, as shown by continuous glucose monitoring, and ameliorates metabolic syndrome 		120
PD-35 The application of mobile APP for diabetic self-management in adolescent with Type 1 diabetes 		120
PD-36 Clinical course after discontinuation of the SGLT2 inhibitor tofogliflozin 		120
PD-37 The effect of rice-bran dietary fiber on postprandial blood glucose for Type II diabetic patients 		121
PD-38 The effect of SGLT2 inhibitors on drug-naive obese type 2 diabetes mellitus patients 		121
PD-39 Plasma serpinB1 levels are strongly correlated with circulating ANGPTL8 levels in patients with type 2 diabetes 		121
PD-40 DPP-4 inhibitors treatment in Chinese type 2 diabetes patients: A meta-analysis 		122
PD-41 Identical hypoglycaemic effect of teneligliptin with linagliptin in type 2 diabetes with chronic kidney disease 		122
PD-42 The study of anti-diabetic drugs treatment (Monotherapy, Bitherapy, and Tritherapy) among diabetic mellitus patients in Preah Kossamak Hospital, Cambodia 		122
PD-45 The effect of Djulis hull on postprandial plasma glucose of Type II diabetes patients 		122
PD-46 The effect of transglucosidase for improving postprandial blood glucose of Type II diabetes patients 		123
PD-47 Efficacy and safety of once-weekly GLP-1 RA in patients with type 2 diabetes treated with DPP-4 inhibitor 		123
PD-48 Liraglutide add-on to insulin improved glycaemia but exhibited short durability after cessation in type 1 diabetes with residual insulin secretion 		123
PD-49 Effects of teneligliptin in elderly patients with type 2 diabetes mellitus 		124
PD-50 The effectiveness and safety of sulfonylureas in type 2 diabetes with chronic kidney disease in center Taiwan 		124
PD-51 Baseline characteristics of patients initiating insulin treatment for type 2 diabetes in the Western Pacific: Evidence from the VISION Study 		124
PD-52 Long-term efficacy and safety of add-on therapy of vildagliptin in type 2 diabetes mellitus with insulin treatment 		125
PD-53 Comparison of eGFR before and after the administration of ipragliflozin using creatinine and cystatin C as indicators 		125
PD-54 Long-termefficacy of hydrophilic or lipophilic statin therapy in diabetic Taiwanese 		125
PD-55 Effects of intervention by a nutrition support team on serum albumin level in diabetic patients 		126
PD-56 Titration when switching from insulin degludec to insulin glargine U300 among Japanese diabetes patients 		126
PD-57 Study of patients who presented to the emergency outpatient department with the chief complaint of hypoglycemia 		126
PD-58 The acute efficacy and safety of dulaglutide in Japanese adults with type 2 Diabetes Mellitus 		127
PD-59 Inhibition of central GSK3 regulates body weight and glucose metabolism 		127
PD-60 Factors related to diabetes’ ABC control in a Taipei community hospital – A prospective follow-up study 		127
PD-61 Health economic impact of hypoglycemia among 7,289 insulin-treated patients with diabetes: Results from an International survey in 9 countries 		128
PD-62 Fibrinogen level was correlatedwith glycemic control, not with lipid profiles in type 2 DM patients 		128
PD-63 Effect of astaxanthin and astaxanthin formula on thrombotic risk factors in type 2 DM patients 		128
PD-64 The usefulness of newly long acting insulin as Degludec for 2 years in Japanese Type 1 Diabetes 		129
PD-65 Evaluation of the CGMs in type-2 diabetic patients switched from Liraglutide and Insulin Degludec to Liraglutide and Insulin Degludec/Aspart 		129
PD-66 Increased body mass index may attenuate the effect of sitagliptin on glucose control 		130
PD-67 The efficacy of DPPIV-inhibitor therapy among adult Chinese patients with diabetes mellitus in Singapore 		130
PD-68 Fenretinide decreases insulin resistance and blood pressure, and inhibits macrophage inflammatory mediators via the peroxisome proliferator activated receptor pathway 		130
PD-69 Self-reported hypoglycemic rates and insulin regimen among 7289 insulin-treated adult patients with diabetes: An International survey in 9 countries 		131
PD-71 Self-reported hypoglycemia in insulin-treated patients with diabetes: Results from an international survey of 7289 patients from 9 countries 		131
PD-72 The effects of lobeglitazone, a novel thiazolidinedione (TZD), on bone mineral density in mice 		131
PD-73 Risk stratification of diabetic foot disease among new patients in a community based Haemodialysis Programme 		132
PD-74 The effect of risk stratification on 1st year lower limb amputation in diabetic patient starting haemodialysis in community setting 		132
PD-75 Comparison of glycemic control in Asian and non-Asian T2D patients initiating insulin glargine 100 U/mL as add-on therapy to OADs 		132
PD-76 A reduced risk of hypoglycaemia with insulin degludec vs. insulin glargine U100 in Asian insulin-naïve patients with T2D 		133
PD-77 Sequential changes in clinical findings of diabetic patients by replacing insulin glargine with degludec 		133
PD-78 Efficacy and safety of mitiglinide versus acarbose for treatment of Chinese patients with type 2 diabetes: Open, multi-center, randomized study 		134
PD-79 Mechanisms of postprandial suppression of hepatic AMPK activity through insulin-PI 3-kinase pathway 		134
PD-80 The effect of vitamin D-rich diet on advanced glycation end products in overweight and obese women: VINTAGE trial 		134
PD-81 Effects of resistance exercise training in type 2 diabetes 		135
PD-82 Real-World (RW) treatment patterns in patients with T2DM newly initiated with antihyperglycemic (AHA) medications in the US 		135
PD-83 Efficacy of canagliflozin (CANA) in combination with metformin (MET) in patients with T2DM: Results from 3 studies 		136
PD-84 Real-world 12-month outcomes of patients with type 2 diabetes mellitus (T2DM) treated with canagliflozin in a US managed care setting 		136
PD-85 Efficacy of canagliflozin (CANA) versus dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients with T2DM: Results from RCTs and Real-World (RW) study 		136
PD-87 Real-world evaluation of weight loss in patients with T2DM treated with canagliflozin (CANA) – An electronic healthrecord (EHR)-based study 		136
PD-88 Semaglutide reduces appetite and energy intake, improves control of eating and provides weight loss in subjects with obesity 		137
PD-89 Semaglutide improves postprandial glucose and lipid metabolism and delays first-hour gastric emptying in subjects with obesity 		137
PD-90 Renal effects of canagliflozin in patients with Type 2 diabetes 		137
PD-91 Self-monitoring of blood glucosewith smart-phone based data sharing improved glycemic control in patients with diabetes 		138
PD-92 The impact of CGMS in subjects of inadequately controlled type 2 diabetes under intensive glycemic control 		138
PD-93 Dietary patterns influence blood sugar and lipid control among type 2 diabetic patients in Taiwan– A pilot study 		138
PD-94 Relationship between indices of daily glycemic variability and long-term glucose fluctuations 		139
PD-95 Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in subjects with type 2 diabetes (SUSTAIN 1) 		139
PD-96 Efficacy and safety of once-weekly semaglutide versus sitagliptin as add-on to metformin and/or thiazolidinediones in subjects with T2D (SUSTAIN 2) 		140
PD-98 Efficacy and tolerability of gliclazide MR 60 mg in the management of type 2 diabetes: Analysis of the EasyDia Trial 		140
PD-100 Clinical effectiveness study of SGLT2 inhibitors as added-on therapy for 149 insulin treated type 2 diabetes patients 		140
PD-101 Outcomes of holistic care for patients with type 1 diabetes (T1D) by multidisciplinary teams in Thailand 		141
PD-102 Effect of dapagliflozin in Japanese type 2 diabetes patients who have inadequate glycemic control 		141
PD-103 To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus 		141
PD-104 Effectiveness of the personalized manager service on postprandial blood glucose management in Taiwanese patients with diabetes 		142
PD-105 The clinical effect of dapaglifrozin in type 2 diabetics with obesity: Retrospective analysis in a real practice setting 		142
PD-106 Comparison of short-and long-acting glucagon-like peptide 1 receptor agonists on postprandial glucose excursion, insulin and glucagon secretions and gastric emptying 		142
PD-107 The efficacy of liraglutide for treatment of type 2 diabetes 		143
PD-108 Beneficial effect on postprandial glucose excursion by ingestion of boiled barley rice and Japanese side dishes 		143
PD-109 Efficacy and safety of gemigliptin as add-on therapy in patients with type 2 diabetes inadequately controlled on metformin and glimepiride 		143
PD-110 Efficacy and safety of gemigliptin in type 2 diabetes patients with moderate to severe renal impairment 		144
PD-112 Current status of metformin or acabose in addition to insulin therapy in adult patients with T1DM in Guangdong, China 		144
PD-113 Patient responses following hypoglycemia in the IO-HAT study: A population-based study of insulin-treated patients with diabetes in 9 countries 		145
PD-114 Once-weekly DPP-4 inhibitors: The clinical efficacy and treatment satisfaction in 51 Japanese patients with type 2 diabetes mellitus 		145
PD-115 Deteriorating glycemic control after fixed-dose anti-diabetic combinations were equally shifted to free-drugs regimens 		145
PD-116 The effects of once-weekly semaglutide on beta-cell function in subjects with type 2 diabetes 		145
PD-117 Comparison of the efficacy and safety of insulin degludec between type 1 and type 2 diabetes 		146
PD-118 Long-term glucose lowering effects of sitagliptinmonotherapy and dietary contents in Japanese individuals with type 2 diabetes 		146
PD-119 Eating habits of 84 diabetic out-patients with increased HbA1c level or body weight in SGLT2 inhibitors treatment 		147
PD-120 Linagliptin reduces the diabetic nephropathy score, DN_Score, in patients with T2DM and microalbuminuria: A predefined substudy from the MARLINA-T2D™trial 		147
PD-121 Incretin-based therapy has better glycemic sustainability and less variability in patients with diabetes on stable anti-diabetic medications 		147
PD-122 A real world experience of long-acting GLP-1 receptor agonists in a medical center in southern of Taiwan 		147
PD-123 The short-term glycemic effects of a smartphone-based communication application management 		148
PD-124 Influence of digestible carbohydrate in glycaemic index of healthy individuals and diabetes 		148
PD-125 Efficacy and safety comparison of sitagliptin and glimepiride in elderly Japanese patients with type 2 diabetes: START-J 		148
Delay Diabetes Complication: What Can We Do? 		149
PE-01 Factors associated with diabetic retinopathy in patients with early and late diagnosed type 2 diabetes in Bangladeshi population 		149
PE-02 Prevalence of retinopathy in population with prediabetes in China: Results from a cross-sectional survey and retrospective analysis 		149
PE-03 Risk factors of arterial stiffness in patients with type 2 diabetes 		150
PE-04 Cases of diabetes complicated by sexual dysfunction 		150
PE-05 To prevent hemo-dialysis therapy due to diabetic nephropathy. High-risk approach or population approach? From doctors’ association’s point of view 		150
PE-06 Frequency of using eye care among persons with diabetes and diabetic retinopathy in DIY: A rural-urban comparison 		151
PE-07 Campaign held for clinic outpatients to visit an ophthalmologist at least once a year 		151
PE-08 Tissue inhibitor of metalloproteinase-1 is associated with carotid plaque score in patients with type 2 diabetes and hypertension 		151
PE-10 Influencing factors of intention to receive examination of diabetes complications 		152
PE-11 Inflammation associated with intraocular pressure in the subjects with metabolic syndrome 		152
PE-13 Current metabolic status affects urinary liver-type fatty-acid binding protein in patients with type 2 diabetes 		152
PE-14 Carotid extra-media thickness is associated with intimamedia thickness and renal dysfunction in Korean patients with type 2 diabetes 		152
PE-15 Evaluation of the potential nephroprotective effects of metformin in diabetes – A systematic review 		153
PE-16 The frequency of microalbuminuria in patients with newly diagnosed type 2 diabetes mellitus in suburban population of Jakarta, Indonesia 		153
PE-17 Dyslipidemia in children with diabetes 		153
PE-18 GLP-1 action attenuates prostate cancer growth and progression 		154
PE-19 Effects of arecoline on insulin signaling in human endothelial cells 		154
PE-20 The relationship between type 2 diabetes and hearing impairment 		155
PE-21 The effectiveness of multiplace chamber hyperbaric oxygen therapy in treating refractory critical limb ischemia patients complicated with diabetes mellitus 		155
PE-22 High prevalence of early small fiber dysfunctions in patients with type 2 diabetes detected by thermal thresholds of lower extremities 		155
PE-23 Overexpression of GLP-1 receptor in hepatocellular carcinoma causes anti-cancer effect of Exendin-4 		156
PE-24 Diabetic retinopathy predicts all-cause mortality in type 2 diabetic patients with chronic kidney disease without overt albuminuria 		156
PE-25 Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease 		156
PE-26 Physical activity and albuminuria were associated with painful diabetic polyneuropathy in type 2 diabetes in an ethnic Chinese population 		157
PE-27 Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK 		157
PE-28 Anterior compartment syndromewith type 1 diabetesmellitus 		157
PE-29 Prevalence of chronic kidney disease among adults with diabetes or prediabetes in China 		157
PE-30 Utilizing team cooperation for improving retinal screening compliance and follow-up of diabetes patients 		158
PE-31 The relationship between mitochondrial dynamics and insulin resistance in diabetes susceptible cybrid cells 		158
PE-32 In situ eNOS/NO up-regulation– A simple and effective therapeutic strategy for diabetic skin ulcer 		158
PE-33 Vegetarian diet is associated with higher SBP and fasting serum triacylglycerol than omnivorous diet in Taiwanese type 2 diabetic 		159
PE-34 A successfully treated case of extremely hyperglycemic crisis accompanied with rhabdomyolysis and acute kidney injury 		159
PE-35 Comparison of clinical characteristics and outcomes of hospitalized patients with pneumonia between diabetic patients and non-diabetic patients in Japan 		159
PE-36 Association of leukocyte subtype counts with chronic inflammation and atherosclerosis in type 2 diabetes mellitus 		160
PE-37 Healing process in diabetic patients with foot ulcer 		160
PE-38 Analysis of clinical factors influencing bone mineral density in Japanese patients with diabetes 		160
PE-39 Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebocontrolled trial 		161
PE-40 Relationship between serum iron with renal function of subjects with diabetes 		161
PE-41 Potential nephroprotective effects of type 2 diabetes therapy: Epidemiologic study for South East Asian and Arab populations in Qatar 		161
PE-42 The correlation between fibrinogen level and arterial stiffness in type 2 DM patients 		162
PE-43 Cilostazol attenuates the severity of peripheral arterial disease in type 2 diabetes: the plasma soluble receptor for advanced glycation end-products 		162
PE-44 Nonalbumin proteinuria as a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy 		162
PE-45 The role of RBP4 receptor on the pathogenesis of diabetic kidney 		163
PE-47 Temporal pattern of plasma glucose levels during oral glucose tolerance test and the association with cardiovascular risk 		163
PE-48 HbA1C variability is not associated with renal outcomes in diabetic nephropathy with chronic kidney disease stage 3-5 		163
PE-49 Effects of t-PA and PAI-1 on the macro-vascular complications in type 2 diabetes 		163
PE-50 To increase smoking cessation rate among diabetic smokers who participate in smoking cessation clinics by means of effective health education 		164
PE-51 Recurrent left hemichoreic movement following to severe hyperglycemia in type 2 diabetes mellitus 		164
PE-52 A nursing experience of implementing interprofessional practice on a diabetic foot ulcer patient 		164
PE-53 Periodontitis prevention program effectively reduced the incidence of periodontitis in diabetic patients 		165
PE-54 Associations of glycated hemoglobin A1c and glycated albumin with subclinical atherosclerosis in the Chinese population with impaired glucose regulation 		165
PE-55 Asymmetric Dimethylarginine correlates significantly with tumour necrosis alfa but not with brachial ankle pulse wave velocity in the T2DM-METS 		165
PE-56 Limb preservation affects survival for diabetic patients with infectious foot gangrenes 		166
PE-57 TG/HDL-C ratio predicts development of albuminuria in type 2 diabetes with ACR <10 mg/gm. A prospective cohort study 		166
PE-58 Specific responsibility team for vascular interventions in diabetic foot decreases major lower limb amputation rate 		166
PE-59 Outcome analysis of diabetic patients with or without albuminuria 		167
PE-60 A study of increasing access to diabetic retinopathy screening and referral if indicated 		167
PE-61 Correlation of glycemic control and arterial stiffness in patients with type 2 diabetes mellitus 		167
PE-62 DESMOND…Does it deliver for Aboriginal and Torres Strait Islander people 		167
PE-63 A novel scoring system for the early detection of diabetic kidney disease in patients with type 2 diabetes 		168
PE-64 The relationship between CVR-R and 2-year glycemic control in type 2 diabetic patients 		168
PE-65 The effect of nutrition counseling on glycemic control and cognitive function in type 2 diabetic patients 		168
PE-66 The effects of different Korean red ginseng fractions on diabetic progression and diabetic complication markers in obese diabetic NSY/Hos mice 		169
Psychosocial Status of Diabetes: What Have We Learned? Psychosocial Perspectives on Diabetes Caring and Health Behavior 		169
PF-01 HbA1c is not a biomarker for depression in the era of DPP-4 inhibitors 		169
PF-02 Finding patients who do not have a sense of urgency to improve hyperglycemia 		169
PF-03 Effect of memory training on cognitive function in diabetes patients 		170
PF-04 Shift in parenting style in parents of children with type1 diabetes 		170
PF-05 The effect of healthcare word-of-mouth and behavioral status on improving patient self-management: 1-on-1 interviews with volunteers regarding their own experiences 		170
PF-06 Effects of community-based self-weighing campaign over holiday seasons: Effects on weight loss, rates of diabetes and prediabetes, and medical costs 		171
PF-07 A follow-up study of treatment beliefs to insulin of patients with failure to oral hypoglycemic agents 		171
PF-08 The correlation between health behavior and self-efficacy of obese diabetic patients 		171
PF-09 Effects of nutritional care to diabetic elderly in the long-term care settings 		172
PF-10 The effectiveness of the Steno Balance Cards on complementary health management of poorly controlled diabetes patients 		172
PF-11 Diabetes related distress among patients with type 2 diabetes in Taiwan 		172
PF-12 Utilizing transtheoretical model for transforming a uncooperative diabetes nephropathy patient into a cooperative patient undergoing hemodialysis 		173
PF-13 The co-occurrence of depressive symptoms and cognitive impairment and its relationship with diabetes self-care behaviors 		173
PF-15 Psychological benefits of peer support: Implications for peer support programs and diabetes self management and support in China 		174
PF-16 The effect of mental disorders on glycemic control of patients with type 2 diabetes 		174
PF-17 Characteristics of type 2 diabetes patients with low aerobic exercise capacity 		174
PF-18 The association between self-reported sleep quality and arterial stiffness 		175
PF-19 The applicability research of portion-controlled tableware developed by Taiwanese Association of Diabetes Educators in common Chinese food 		175
PF-20 Predictors of polypharmacy among diabetes in Japan 		176
PF-21 Using models of group therapy in diabetes patients with enhancing the effectiveness of self-health care 		176
PF-22 Associations between insomnia and glycemic control in Hong Kong Chinese patients with type 2 diabetes 		176
PF-23 The validation of the community pharmacists’ motivation to lifestyle support for diabetics: the effect of “3 star pharmacists training program” 		177
PF-24 The relationship between quality of life and health beliefs in diabetes patients 		177
Diabetes Education: Focus on Minds 		177
PG-01 The effect on condition control among type 2 diabetic patients using diabetes conversation map tools 		177
PG-02 The comparison of different health education tools and their effects in glucose management for type II diabetes patients 		178
PG-03 Fruit-eating habit in Hong Kong people with diabetes 		178
PG-04 Improvement of blood glucose in type II diabetes mellitus after health education 		178
PG-05 Metformin for patients under iodine-based contrast medium 		179
PG-06 Analysis of correlation between eating speed and blood glucose control among diabetic patients from a medical center in southern Taiwan 		179
PG-07 Analysis of the effectiveness of patients’ self-management of exercise and control of blood glucose 		179
PG-08 A probe into the improvement in HbA1c among diabetic patients on multiple insulin injections along with carbohydrate substitute diet 		180
PG-09 Analysis of food order’s effect on postprandial glycated hemoglobin level among diabetic patients from a medical center in southern Taiwan 		180
PG-10 A probe into the analysis of cause of hypoglycemia among patients joining diabetes health improvement program 		180
PG-11 The investigation of mobile communication software “Line” intervention for diabetes nutrition and health education 		180
PG-12 Symptom management education program for people with type 2 diabetes 		181
PG-13 Elucidation of lifestyles that affect the quality of life (QOL) related to the therapy for patients with type 2 diabetes 		181
PG-14 Pilot implementation of a novel post-graduate medical education program: Steno REACH certificate course in clinical diabetes care – Malaysia 		181
PG-15 Combining community resources and utilizing creative health education for improving diabetes support group functions 		182
PG-16 Using healthy diabetes plate for inadequate glycemic control among patients with type 2 diabetes 		182
PG-17 A pilot study on a diabetes link-nurse program to enhance nurse confidence and competence in diabetes care 		182
PG-18 Clinical implication of diabetes education program declaring a goal in life for patients with diabetes mellitus 		183
PG-19 Efforts to improve the enrollment of education and quality of care in type 2 diabetes: experience of a community hospital 		183
PG-20 Effectiveness of the food craving management tool in Korean adolescents 		183
PG-21 Association relationship between periodontal disease severity of periodontal bone loss and clinical features in type 2 diabetic patients 		184
PG-22 Diversified creative diabetes education in Mackay Memorial Hospital, Taiwan 		184
PG-23 Application of intensive diabetes management program by conversation maps on poor controlled insulin naïve type 2 receiving insulin injection 		184
PG-24 The results of nutrition education for diabetes patients in a community in Changhua County, Taiwan 		185
PG-25 Patients’ opinions regarding the continuous glucose monitoring system (CGMS) for self-control in adult patients with type 2 diabetes mellitus 		185
PG-26 The impacts and care trends of type 1 diabetes during the transition phase on patients aged between 16 to 25 		185
PG-27 Effects and predictors of the diabetes conversation map education tools for maintaining glycemic control in patients with type 2 diabetes 		185
PG-29 Investigating the results of utilizing diabetes conversation map for patient blood glucose management 		186
PG-30 Utilizing simplified nutrition screening short form for investigating the nutrition and blood glucose management of elder patients 		186
PG-31 Improvement of glycemic control in Taiwanese patients using modified Diabetes Conversation Map®tools 		187
PG-32 Nurse-led training and education program on insulin pump therapy in Japan 		187
PG-33 The metabolic effect of diabetic education frequency 		187
PG-34 Report of Conversation Map sessions held by a nephrologist 		188
PG-35 Effects and predictors of a STENO intensive multifactorial intervention for HbA1c target achievement in Taiwanese patients with type 2 diabetes 		188
PG-36 Improvements in the views of insulin therapy among Taiwanese patients with type 2 diabetes participating in a STENO multifactorial intervention 		188
PG-37 Impact of drama-based educational program, diabetes theater, on healthcare professionals’ attitudes toward diabetes care: a mixed method evaluation 		189
PG-38 A 6-month nutritional education program for patients with diabetes mellitus is effective to improve HbA1C 		189
PG-39 Performance comparison of average daily risk range obtained by continuous glucose monitoring and self-monitoring of blood glucose in diabetic outpatients 		190
PG-40 The experience of using“Steno Diabetes Dialogue Card” for small group patient education and its effect on glycemic control 		190
PG-41 Scenario-based training to improve nursing staff knowledge and competence in diabetes care 		190
PG-42 Fostering regular exercise behavior to improve metabolic control in patients with diabetes 		191
PG-43 Factors associated with self-care behavior among communitydwelling elderly Taiwanese with diabetes mellitus: findings from the 2009 national health interview survey 		191
PG-44 The effect of dietary intervention in T2DM patients who could not succeed in losing body weight after taking Dapagliflozin 		191
PG-45 The effect of “Diabetic dialogue cards” accompanying peer support for diabetic control 		192
PG-46 Effects of diabetic education onmetabolic parameters in type 2 diabetic patients using insulin 		192
PG-47 Who should give insulin education? 		192
PG-48 Effectiveness of the Diabetes Conversation Map education tools on diabetes-related parameters of outpatients with diabetes 		193
PG-49 Study on the effect of three kinds of food in diabetic patients with hypoglycemia 		193
PG-50 Knowledge, attitudes and practices and its association with glycemic control among type 2 diabetes mellitus patients in a tertiary hospital 		193
PG-51 The impact of small interactive group education plus basal insulin on the glycemic response of type 2 diabetes mellitus 		194
PG-52 The role of diabetic education added to biphasic insulin on the glycemic control of type 2 diabetes mellitus 		194
PG-54 The effectiveness of the camp of “Free Sugar, LOHAS”on type 2 diabetes patients, in the regional teaching hospital 		194
PG-55 Innovation calendar as an education appliance for selfmanagement at home 		195
PG-56 Original diabetes education program including individual selfcare plan“My Goals Sheet” ameliorates long-term glycemic control in patients with diabetes mellitus 		195
PG-57 Dietary survey among type 2 diabetes patients newly enrolling diabetes shared care 		195
PG-58 Effects of peer support activity by using theater for diabetes and CKD Japanese patients 		196
PG-59 Development of the active eating behavior improvement program using the conjoint analysis 		196
PG-60 Impact of medication review by pharmacist toward the medication adherence of type 2 diabetes in outpatient setting 		196
Beta Cell Replacement Therapy and Imaging 		197
PH-01 Different dose of PSP/reg affect biological behavior of beta-cell through induction of autophagy and apoptosis 		197
PH-02 Involvement of glycosphingolipids in the insulin secretion pathway 		197
PH-03 Cytomegalovirus transmission after islet transplant in comparison to other solid organ transplant 		197
PH-04 Identifying a new pathway to regulate AMPK activity under metabolic stress 		198
PH-05 High molecular weight adiponectin and lipid profile in the type-2 diabetes mellitus-Mets 		198
PH-06 Fluoxetine treatment impairs E-cadherin-mediated cell adhesion and altered calcium homeostasis in pancreatic beta cells 		198
PH-08 A comparison of intraportal islet transplantation outcome between intraportal and intravenous injection of bone marrow derived spheroids 		199
PH-09 Impaired incretin-induced insulin secretion in enlarged pancreatic islets in a novel animal model of obese type 2 diabetes 		199
PH-10 The role of leucine in stimulation of adipocyte lipolysis 		199
PH-12 Impaired RBC deformability is associated with pancreatic beta cell dysfunction and diabetic retinopathy in patients with type 2 diabetes 		200
PH-13 Inhibition of RAC1-NOX signaling attenuates high-glucoseinduced CD36 expression in pancreatic β-cells 		200
PH-14 A comparison of sympathetic and parasympathetic nerves density ratio in pancreatic islets in experimental animal model 		200
PH-15 Sympathetic to parasympathetic nerve density ratio change in adipocytes in diabetic animal models 		200
PH-16 Patient with latent autoimmune diabetes in adult (LADA) and autoimmune haemolytic anemia (AIHA), a probable case of autoimmune cross reactivity 		201
Obesity/Diabetes & Bariatric Surgery 		201
PI-01 Relation of MPV with serum PON-1 activity and BA-IMT in diabetic patients with respect to obesity and diabetic complications 		201
PI-03 Effect of bariatric surgery on diabetic complications: the Taiwan diabesity study 		201
PI-04 Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype 		202
PI-05 Association between human adenovirus-36 infection, obesity and glycemia in prospective follow-up of Hong Kong Chinese school children 		202
PI-06 Ferulic acid stimulates muscle insulin signaling pathway in high-fat diet-induced obese mice 		202
PI-07 Young women with severe obesity by gastric sleeve resection of successful weight loss and pregnancy case report 		202
PI-09 The effect of metformin therapy on insulin resistance and Ferriman-Gallwey Scores in patients with idiopathic hirsutism 		203
PI-10 Gender difference on the eating styles and the effect of group diet education in adolescents in Taiwan 		203
PI-11 Decreased serum betatrophin levels after Roux-en-Y gastric bypass in obese Chinese patients with type 2 diabetes: a 1-year follow-up 		203
PI-12 Relationship between gestational weight gain and pregnancy complications, delivery outcome 		204
PI-15 Assessment of the Dynamic Insulin Secretion and Sensitivity Test (DISST) in morbidly obese subjects pre and post gastric bypass 		204
PI-16 Correlation between uric acid and body fat distribution in type 2 diabetes mellitus 		204
PI-17 Correlation between Computed Tomography indices of abdominal fat distributions and lipid metabolism in patients with type 2 diabetes 		205
PI-18 Role of androgen in gender differences in adipocyte fatty acid binding protein induced by body fat content and distribution 		205
PI-19 Controlled attenuation parameter (CAP) have close relationship with the prevalence and the severity of NAFLD in a T2DM population 		205
PI-20 Correlation between insulin sensitivity and pathohistological findings in non-alcoholic fatty liver disease 		206
PI-21 Circulating soluble IL-6 receptor levels and visceral adipocyte size are associated with insulin resistance in morbidly obese subjects 		206
PI-22 Inhibition of local macrophage growth ameliorates obesityassociated adipose tissue inflammation, insulin resistance and hepatic steatosis in HFD-fed mice 		206
PI-23 The weight changes of type 2 diabetes patients with noninsulin antidiabetic drugs: a meta-analysis 		207
PI-24 Association between adolescent pregnancy and sarcopenic obesity in postmenopausal women: The KNHNES 2009–2010 		207
PI-25 Hinokitiol improves insulin action in 3T3-L1 adipocytes 		207
PI-26 Prebariatric screening for diabetes and cardiovascular risk in an interdisciplinary obesity center discloses unexpected gender differences 		207
PI-27 Increased overall mortality and presenting more advanced TNM stage of well differentiated thyroid cancer patients with type 2 DM 		208
PI-28 Effect of bariatric surgery on diabetic nephropathy in obese type 2 diabetes patients in a local retrospective 2 year study 		208
PI-29 Prevalence, clinical characteristics, and risk factors of sarcopenia in overweight patients with type 2 diabetes 		208
PI-31 Role of novel variants of PGC-1α in the pathogenesis of obesity 		209
PI-32 Pioglitazone ameliorates hepatic steatosis via enhancing cytosolic- and autophagy-related lipolysis dominantly mediated by PPAR 		209
PI-35 Adipocyte fatty acid binding protein (A-FABP) is a potential mediator of heart dysfunction and failure related to obesity 		210
PI-36 The association between GFR and metabolic syndrome in Korean population 		210
PI-38 N-acetylcytein improves high-fat-induced overweight and fat accumulation, insulin resistance and glucose intolerance through reducing mitochondrial ROS in visceral fat 		210
PI-39 Short leukocyte telomere length is associated with the FTO rs9939609 polymorphism in non-obese individuals 		211
PI-40 Fatty liver changes after gastric cancer surgery 		211
PI-41 Hypoglycemia occurred in one case after liver transplantation and bariatric surgery 		211
PI-42 The effects of aerobic exercise training on chemerin, apelin, and visfatin in obese young males 		212
Using Big Data for Research and Care in Diabetes 		212
PJ-01 Efficacy of exercise on HbA1c, lipid profiles and BMI changes in diabetic patients participating shared care programs 		212
PJ-02 Mortality and causes of death from 2002 to 2013 in a national sample of diabetic patients in Korea 		212
PJ-03 Impact of intensified frequent clinic visit on glucose control 		213
PJ-04 The analysis of diabetic patients’ blood pressure difference before and after the doctor visit 		213
PJ-05 The impact of hemoglobin A1c on low-density lipoprotein cholesterol estimation by different formula in diabetic patients 		213
PJ-07 Tramadol is a risk factor for hypoglycemia in diabetic patients in Taiwan 		214
PJ-08 Associations between type 2 diabetes and peptic ulcer disease in Taiwan 		214
PJ-10 Meta-analysis of the insulin dosage in Chinese type 2 diabetes patients receiving insulin treatment 		214
PJ-11 Insulin resistance distribution and cut off value in Korea: From the 2008–2010 Korean national health and nutrition examination survey 		214
PJ-12 Comparisons of placebo effect of hypoglycemic drugs between Asian and Caucasian type 2 diabetes patients 		215
PJ-13 Safety and efficacy comparison of different insulin regimens in T2DM patients: A meta-analysis 		215
PJ-14 Metformin as an anticancer agent in breast cancer therapy by regulating tumor associated macrophage polarization and function 		215
PJ-15 LDL-C/APOB and HDL-C/APOA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort 		216
PJ-17 The function of betatrophin in the prediction of nonalcoholic fatty liver and its progress 		216
PJ-18 The association between hyperglycomia and hearing impairment in a Taiwanese adult population 		216
PJ-19 The association of serum uric acid and pre-diabetes in a Taiwanese population 		216
PJ-20 The association of gastric Helicobacter pylori infection, diabetes and pre-diabetes in a Taiwanese population 		217
PJ-21 Gait speed as a predictor of all-cause mortality in communitydwelling elderly people in Japan: The Mima cohort study 		217
PJ-22 Increased risk of heart failure in diabetic patients of Taiwan: Age- and sex-stratified population-based study 		217
PJ-23 Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels 		218
PJ-25 Hyperglycemic crisis is associated with subsequent major adverse cardiovascular events: A nationwide population-based study 		218
PJ-26 Earlymenarche and increased risk of cardiovascular disease in Korean women 		218
PJ-27 Association of complete blood cell counts with metabolic syndrome in an elderly population 		219
PJ-29 Plasma aldosterone concentration predicts the incidence of diabetes mellitus 		219
PJ-30 Angiopoietin-like protein 6 is associatedwith an inflammatory marker and low HDL cholesterol in type 2 diabetes 		219
PJ-31 Association of serum uric acid concentration and microvascular complications in Taiwanese patients with type 2 diabetes mellitus 		220
PJ-32 A reduced risk of diabetes with aripiprazole exposure in schizophrenia patients: A population-based retrospective cohort study 		220
PJ-34 The synergistic effect of serum albumin and globulin on the metabolic syndrome 		220
PJ-35 Elucidating pharmacological beneficial functions of soybean extract on metabolism 		221
PJ-36 Long term DPP4i use reduces joint pain in patients with type 2 diabetes. A study using the national health insurance 		221
PJ-38 Congenital malformations in the first offspring of women with gestational diabetes mellitus in Taiwan–a nationwide survey 		221
PJ-39 Relationship between pre-gestational diabetes and birth defects in the first offspring in Taiwan– a nationwide survey 		222
PJ-40 The relationship of glycemic exposure (HbAlc) to the risk of subclinical hypothyroidism in type 2 diabetes mellitus patients 		222
PJ-41 Infection with hepatitis C virus increases the incidence of dialysis in patients with type 2 diabetes 		222
PJ-42 Effects of hypoglycemia on soluble endoglin in patients with type 2 diabetes 		223
PJ-43 The association of Sitagliptin treatment with all-cause mortality and renal outcomes in diabetic patients with chronic kidney disease 		223
PJ-45 Impaired fasting glucose and risk of cardiovascular mortality in Korean adults 		223
PJ-46 Risk of melanoma in patients with diabetes mellitus: A nationwide retrospective cohort study in Taiwan 		224
PJ-47 Association of severe hypoglycemia with incident atrial fibrillation in type 2 diabetes: a nationwide population-based cohort study 		224
PJ-48 Effect of obstructive sleep apnea on chronic kidney disease– Systematic review and meta-analysis study 		224
PJ-49 The development of human recombinant protein, GAPtin, for diabetes 		225
PJ-50 Type 2 diabetes increases the risk for gout in Taiwan 		225
PJ-51 Impact of metabolic status on the incidence of psoriasis: A Korean nationwide cohort study 		225
PJ-52 Extra virgin olive oil does not cause post-prandial endothelial dysfunction unlike processed butter through protective mechanisms against oxidative stress 		225
PJ-53 Acarbose therapy and diagnosis of colorectal cancer in type 2 diabetes mellitus: A nationwide cohort study in Taiwan 		226
PJ-54 Increased levels of soluble fibrin in human plasma in type 2 diabetic patients 		226
PJ-55 The association between body mass index and cardiovascular event in the Korean general population 		226
PJ-56 Fifteen-year trends in lifestyle modification in patients with diabetes mellitus: From KNHANES 1998–2013 		227
PJ-58 Patterns of search queries of diabetes-related terms: An infodemiological study using Google trends 		227
PJ-59 RBP2R expression and retinol homeostasis in the liver of diabetes 		228
PJ-60 Long-term effectiveness of sulfonylureas in type 2 diabetes 		228
Endocrinology 		228
PK-01 Dynamic risk estimates of outcome in patients with welldifferentiated thyroid cancer after initial treatment 		228
PK-02 Consumptive hypothyroidism associated with hepatic hemangiomas 		228
Author Index 		230
Publication Information 		242
Diabetes Research and Clinical Practice